VEGF-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease.
Pia DavidssonSusanna EketjällNiclas ErikssonAnna WalentinssonRichard C BeckerAnders CavallinAnna BogstedtAnna CollénClaes HeldStefan JamesAgneta SiegbahnRalph A H StewartRobert S StoreyHarvey WhiteLars WallentinPublished in: Cardiovascular research (2023)
This is the first large-scale cohort study to demonstrate that both VEGF-D plasma levels and VEGFD genetic variants are independently associated with CV outcomes in patients with ACS and CCS. Measurements of VEGF-D levels and/or VEGFD genetic variants may provide incremental prognostic information in patients with ACS and CCS.